Cargando…

P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL

Detalles Bibliográficos
Autores principales: Zhou, Hu, Hou, Ming, Shi, Yan, Jin, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430295/
http://dx.doi.org/10.1097/01.HS9.0000973260.33694.1d
_version_ 1785090928774479872
author Zhou, Hu
Hou, Ming
Shi, Yan
Jin, Jie
author_facet Zhou, Hu
Hou, Ming
Shi, Yan
Jin, Jie
author_sort Zhou, Hu
collection PubMed
description
format Online
Article
Text
id pubmed-10430295
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104302952023-08-17 P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL Zhou, Hu Hou, Ming Shi, Yan Jin, Jie Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430295/ http://dx.doi.org/10.1097/01.HS9.0000973260.33694.1d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Zhou, Hu
Hou, Ming
Shi, Yan
Jin, Jie
P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL
title P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL
title_full P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL
title_fullStr P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL
title_full_unstemmed P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL
title_short P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL
title_sort p1596: efficacy and safety of ql0911 in adult patients with chronic primary immune thrombocytopenia: a multicenter, randomized, double-blind, placebo-controlled, phase iii trial
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430295/
http://dx.doi.org/10.1097/01.HS9.0000973260.33694.1d
work_keys_str_mv AT zhouhu p1596efficacyandsafetyofql0911inadultpatientswithchronicprimaryimmunethrombocytopeniaamulticenterrandomizeddoubleblindplacebocontrolledphaseiiitrial
AT houming p1596efficacyandsafetyofql0911inadultpatientswithchronicprimaryimmunethrombocytopeniaamulticenterrandomizeddoubleblindplacebocontrolledphaseiiitrial
AT shiyan p1596efficacyandsafetyofql0911inadultpatientswithchronicprimaryimmunethrombocytopeniaamulticenterrandomizeddoubleblindplacebocontrolledphaseiiitrial
AT jinjie p1596efficacyandsafetyofql0911inadultpatientswithchronicprimaryimmunethrombocytopeniaamulticenterrandomizeddoubleblindplacebocontrolledphaseiiitrial